Healio1d
Rezpegaldesleukin gets FDA fast track designation for atopic dermatitis
The FDA has granted a fast track designation to rezpegaldesleukin for treating patients aged 12 years and older with moderate ...
Monthly Prescribing Reference19d
Emetogenic Potential of Antineoplastic Agents
1 Frequency of emesis in the absence of effective antiemetic prophylaxis. 2 May be highly emetogenic in certain patients. 3 Routine premedication may not be required. An individualized approach is ...
Pharmaceutical Technology28d
Aldesleukin by Iltoo Pharma for Miscarriage: Likelihood of Approval
Aldesleukin is under clinical development by Iltoo Pharma and currently in Phase II for Miscarriage. According to GlobalData, Phase II drugs for Miscarriage does not have sufficient historical data to ...
Pharmaceutical Technology1mon
Aldesleukin by Iltoo Pharma for Bipolar Disorder (Manic Depression): Likelihood of Approval
Aldesleukin is under clinical development by Iltoo Pharma and currently in Phase II for Bipolar Disorder (Manic Depression). According to GlobalData, Phase II drugs for Bipolar Disorder (Manic ...
Frontiers2y
State-of-the-art combination treatment strategies for advanced stage non–small cell lung cancer
Non–small cell lung cancer (NSCLC) is the most abundant type of epithelial lung cancer being diagnosed after 40% of invasions of excrescence in pulmonary tissues. According to WHO, 30% of NSCLC ...